Picture of Valerio Therapeutics SA logo

ALVIO — Valerio Therapeutics SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapMomentum Trap

Brief: Onxeo H1 net loss stable at 11.6 million euros

July 28 (Reuters) - ONXEO SA  C4X.PA : 
    * H1 REVENUE EUR 3.4 MILLION VERSUS EUR 1.9 MILLION YEAR 
AGO 
    * H1 OPERATING LOSS EUR 11.3 MILLION VERSUS LOSS OF 11.2 
MILLION YEAR AGO 
    * AT JUNE 30, 2017, THE COMPANY HAD CONSOLIDATED CASH 
POSITION OF 27.7 MILLION 
    * H1 NET LOSS EUR 11.6 MILLION VERSUS LOSS OF EUR 11.2 
MILLION YEAR AGO 
 
Source text: http://bit.ly/2veLn3Q 
Further company coverage:  C4X.PA  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))

Recent news on Valerio Therapeutics SA

See all news